Breaking Beijing Restaurants Revive Imperial Chinese Cuisine Multiple Fights Erupt During Saints-Cowboys Joint Practice; Player Suffers Heat Exhaustion South Korea, U.S. Shorten Joint Military Drills Assam Floods Intensify, Experts Urge Enhanced Early Warning and Disaster Planning Former Fauci Adviser Pleads Guilty to Defrauding U.S. Over COVID-19 Records

Tuesday August 18, 2026

Reporter

Replimune, Inc.

4Articles Published

4Communities Covered

Published Articles

Press Release

Replimune Reports Fiscal First Quarter 2027 Financial Results and Provides Corporate Update

Aug 17

Press Release

Replimune Announces Pricing of $150 Million Underwritten Offering

Aug 10

Press Release

Replimune Announces FDA Accelerated Approval of TUDRIQEVTM in Combination with Nivolumab for Unresectable Advanced Cutaneous Melanoma After Progression on an anti-PD-1 Based Regimen

Aug 6

Press Release

Replimune Announces Favorable Outcome of FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee Meeting for RP1 in Advanced Melanoma

Jul 30